Macula Society 2023

Therapeutic effect of pegcetacoplan on RPE and photoreceptor integrity in GA in the phase Ill OAKS/DERBY trials

Pegcetacoplan in Geographic Atrophy: 24-Month Efficacy Results From the Phase 3 OAKS and DERBY Trials – Impact on Retinal Cells

Access Resources

24-Month Safety Results From the OAKS and DERBY Trials With Further Characterization of Exudative Age-Related Macular Degeneration

Access Resources

Back to Conference Resources

GA Congress Presentations

The following information is available for educational purposes only. The information is not to be re-purposed or re-used in its current form or presentation for any personal or professional use. Apellis reserves the right to withdraw, modify or change the information that is available on this website at any time.

Macula Society 2023

Back to Conference Resources

Report an Adverse Event or Product complaint

Ask a Medical Question

Connect with an MSL

Landing